According to the MAH’s representative, there is a justified suspicion that the Arpixor 30 mg, 56 tablets batch does not meet quality requirements regarding appearance. Potential effects: lack of treatment effectiveness or unpredictable drug action.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Arpixor 30 mg from batch P1. Patients who have this product should return it to a pharmacy and, in case of doubts, consult a doctor or pharmacist.
The Chief Pharmaceutical Inspector withdrew Arpixor 30 mg, batch P1, from the market throughout the country and granted the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related